Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_assertion type Assertion NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_head.
- NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_assertion description "[SEREX technology combined with SSH method is an effective research strategy which can filter tumor antigen with high specific character; the corresponding autoantibodies of TM4SFl, ClD, TIZ, BARDI, FXRI, and OV-189 gene's recombinant antigen in serum can be regarded as the biomarkers which are used to diagnose ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_provenance.
- NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_assertion evidence source_evidence_literature NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_provenance.
- NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_assertion SIO_000772 26513889 NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_provenance.
- NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_assertion wasDerivedFrom befree-2016 NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_provenance.
- NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_assertion wasGeneratedBy ECO_0000203 NP1295314.RAe6mtt-W4TWtJ5VQt7hQGViG31QeyCGkyc0X0R02HU9A130_provenance.